Rapid detection of drug-resistant tuberculosis (TB) has become increasingly
important in the era of pandemic human immunodeficiency virus infection an
d antibiotic resistance. The identification of the molecular correlates of
antibiotic resistance in Mycobacterium tuberculosis have engendered the dev
elopment of DNA-based assays for the identification of drug-resistant TB. T
his review summarizes the recent discoveries concerning resistance to isoni
azid, rifampin, pyrazinamide, ethambutol, streptomycin, amikacin, kanamycin
and the quinolones.